Publications
Q-Plex™ Technology offers quality imaging and data analysis
for every application and budget
FDA EUA for SARS-CoV-2 IgG Antibody Test
For Immediate Release Quansys Biosciences Receives FDA Emergency Use Authorization for its SARS-CoV-2 IgG Antibody Test that Provides Exceptional Clinical Performance Lede: Quansys Biosciences to release the first multiplexed serological assay for SARS-CoV-2 to be...
Human Serological SARS-CoV-2 (4-Plex) ELISA
For Immediate Release Quansys Biosciences Releases Multiplex Human Serological SARS-CoV-2 (4-plex) ELISA Lede: Quansys Biosciences to release the first multiplexed serological assay for SARS-CoV-2 to be used in surveillance studies. Logan, UT, April 8, 2020 — Quansys...
Quansys to present at Biomarkers & World CDx Conference
For Immediate Release Contact: scall@quansysbio.com Quansys to present on multiplexing protein biomarkers in Precision Medicine at the 10th Annual, Clinical, Biomarkers & World CDx Conference Logan, UT, August 22, 2019—Quansys Biosciences, Inc. a pioneer in...
Evaluation of antiviral therapies in respiratory and neurological disease models of Enterovirus D68 infection in mice
An interesting publication from our neighbor, Utah State University! They looked into the use of guanidine as an antiviral treatment for Enterovirus D68. Thank you for sharing this with us!
Lower price for nutrition assessment tool expands global access
PATH and Quansys Biosciences, Inc. improve access of the Q-Plex™ Human Micronutrient Array for low- and middle-income countries with a new price of US$1.43 per analyte, making it even more affordable and accessible to the countries that need it most.
Effect of prenatal EPA and DHA on maternal and umbilical cord blood cytokines
A clinical trial using our Q-Plex; Human Cytokine – Screen IR (16-plex). They performed this study to investigate the effect of prenatal eicosapentaenoic acid (EPA)- and docosahexaenoic acid (DHA)-rich fish oil supplementation on maternal and fetal cytokine production.
Therapeutic Compositions and Methods for Treating Infections
This disclosure describes, in one aspect, a composition that includes a transgenic pathogen that expresses a heterologous pathogen associated molecular pattern (PAMP). In some embodiments, the pathogen may be attenuated. In some embodiments, the pathogen can include T. cruzi.
Uncorrelated healing response of tendon and ear injuries in MRL highlight a role for the local tendon environment in driving scarless healing
How does the systemic environment influence scarless healing of certain tissues? These scientists had the objective to investigate the potential of the local tendon environment in driving scarless healing (1) by comparing the systemic response and the healing capacity associated with ear and tendon injuries in MRL/MpJ mice, and (2) by comparing intrinsic healing properties between MRL/MpJ and normal healer C57Bl/6 tendons.
Operational performance of a Plasmodium falciparum ultrasensitive rapid diagnostic test for the detection of asymptomatic infections in Eastern Myanmar.
An HRP2-based ultrasensitive RDT was developed to improve the detection of low density infections of asymptomatic malaria was evaluated during prevalence surveys within a malaria elimination program in a low transmission area of Eastern Myanmar.
Structure and Composition Define Immunorecognition of Nucleic Acid Nanoparticles
Here, we describe the first systematically studied immunological recognition of 25 representative RNA and DNA NANPs selected to have different design principles and physicochemical properties. We discover that, unlike traditional TNAs, NANPs used without a delivery carrier are immunoquiescent.